Literature DB >> 28385367

[Radiation-induced bronchiolitis obliterans with organizing pneumonia].

J Ducray1, S Vignot2, A Lacout3, I Pougnet4, P-Y Marcy5, C Chapellier6, N Foray7, A Creisson8, J Thariat9.   

Abstract

Bronchiolitis obliterans with organizing pneumonia is an inflammatory reaction that can occur as a consequence of various pulmonary affections. Radiotherapy is not the sole and systematic cause of bronchiolitis obliterans with organizing pneumonia. Radiation-induced should not be confused with post-radiation, dose-dependent, inflammatory pulmonary fibrosis, which is non-immunological and located within the irradiation field. The role of immunity, local inflammation and individual radiosensitivity in bronchiolitis obliterans with organizing pneumonia is not well defined. Bronchiolitis obliterans with organizing pneumonia represents 1% of irradiated patients with breast cancer. It results in fever (flu-like symptoms), a rather dry cough and dyspnea. In the post-radiation context, bronchiolitis obliterans with organizing pneumonia may be diagnosed several months and up to a year after breast irradiation. The treatment consists of prolonged steroids or immunosuppressants, which do not prevent chronicity in 15% of patients and death in up to 5% of cases, the remaining 80% of patients healing without sequelae.
Copyright © 2017 Société française de radiothérapie oncologique (SFRO). Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  BOOP; Breast cancer; Bronchiolite oblitérante avec organisation pneumonique; Bronchiolitis obliterans with organizing pneumonia; Cancer du sein; Corticostéroïdes; Radiation therapy; Radiothérapie; Steroid

Mesh:

Year:  2017        PMID: 28385367     DOI: 10.1016/j.canrad.2016.12.001

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  1 in total

1.  Radiation-induced pseudomembranous tracheobronchitis: A report of two cases.

Authors:  Hye Sook Choi
Journal:  Thorac Cancer       Date:  2022-07-06       Impact factor: 3.223

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.